Phase I study of cetuximab (CET) in combination with 5-fluorouracil (5-FU), cisplatin (CP), and radiotherapy (RT) in patients with locally advanced squamous cell anal carcinoma (LAAC)

被引：17
|
作者：
Olivatto, L. O. [1 ]
Meton, F. [1 ]
Bezerra, M. [1 ]
Cardoso, A. [1 ]
Araujo, C. M. [1 ]
Castro, L. [1 ]
Moura, R. [1 ]
Pereira, V. [1 ]
Ferreira, C. G. [1 ]
机构：
[1] Inst Nacl Canc, Rio De Janeiro, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.4609
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4609
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma
    Olivatto, Luis O.
    Vieira, Fernando M.
    Pereira, Bruno V.
    Victorino, Ana P.
    Bezerra, Marcos
    Araujo, Carlos M.
    Erlich, Felipe
    Faroni, Lilian
    Castro, Leonaldson
    Lusis, Edward C.
    Marins, Alessandra
    Ferreira, Carlos Gil
    [J]. CANCER, 2013, 119 (16) : 2973 - 2980
  • [2] Phase 1 Study of Cetuximab in Combination With 5-Fluorouracil, Cisplatin, and Radiotherapy in Patients With Locally Advanced Anal Canal Carcinoma
    Moreno, Victor
    Garcia-Carbonero, Rocio
    Maurel, Joan
    Feliu, Jaime
    [J]. CANCER, 2014, 120 (03) : 454 - 456
  • [3] Reply to Phase 1 Study of Cetuximab in Combination With 5-Fluorouracil, Cisplatin, and Radiotherapy in Patients With Locally Advanced Anal Canal Carcinoma
    Olivatto, Luis
    Ferreira, Carlos Gil
    [J]. CANCER, 2014, 120 (03) : 456 - 456
  • [4] Cetuximab plus chemoradiation with cisplatin and 5-fluorouracil (5-FU) in locally advanced unresectable esophageal squamous cell carcinoma.
    Sunpaweravong, P.
    Sunpaweravong, S.
    Sangthawan, D.
    Pinaikul, S.
    Attasaranya, S.
    Dechaphunkul, A.
    Mitarnun, W.
    Fungthammasarn, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer
    Leon, Otilia
    Guren, Marianne G.
    Radu, Calin
    Gunnlaugsson, Adalsteinn
    Johnsson, Anders
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 (18) : 2740 - 2746
  • [6] Phase I study of cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil (5-FU) in patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).
    Humblet, Y
    Vega-Villegas, E
    Mesia, R
    Awada, A
    Geoffrois, L
    Borel, C
    Hitt, R
    Amellal, N
    Bessa, EH
    Bourhis, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 491S - 491S
  • [7] Cetuximab plus 5-fluorouracil (5-FU) in advanced cutaneous squamous cell carcinoma: A retrospective analysis
    Huynh, J.
    Eigentler, T.
    Moritz, R.
    Schlaak, M.
    Dobos, G.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 71 - 71
  • [8] Phase I-II study with docetaxel (D), cisplatin (C) and 5-Fluorouracil (5-FU) in patients with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)
    Schrijvers, D
    Van Herpen, C
    Kerger, J
    Joosens, E
    Brandely, M
    Vermorken, JB
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 75 - 75
  • [9] Phase I-II study with docetaxel (D), cisplatin (C) and 5-fluorouracil (5-FU) in patients (pts) with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)
    Schrijvers, D
    Van Herpen, C
    Kerger, J
    Joosens, E
    Le Bouder, C
    Castelijns, J
    Awada, A
    Vermorken, JB
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S164 - S164
  • [10] Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer
    Bleiberg, H
    Conroy, T
    Paillot, B
    Lacave, AJ
    Blijham, G
    Jacob, JH
    Bedenne, L
    Namer, M
    DeBesi, P
    Gay, F
    Collette, L
    Sahmoud, T
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (08) : 1216 - 1220
12345